Founded in Irvine, California, Edwards Lifesciences Corporation is a global medical technology company dedicated to improving the lives of patients with cardiovascular disease and critical illnesses. The company's core mission is to advance innovative technologies that address structural heart disease and provide critical care and surgical monitoring solutions. Edwards Lifesciences offers a range of products including transcatheter heart valve replacement and repair solutions, as well as critical care monitoring technologies, targeting markets in the United States, Europe, Japan, and internationally.
Notable figures affiliated with Edwards Lifesciences include its pioneering leadership team and a network of esteemed clinical researchers. The company has achieved significant milestones such as the development of the PASCAL and Cardioband transcatheter valve repair systems. Edwards Lifesciences' impact is profound, with its patient-focused innovations contributing to enhanced treatment outcomes and quality of life for individuals battling cardiovascular conditions globally.
